CN1511553A - 一种小儿退热药物 - Google Patents
一种小儿退热药物 Download PDFInfo
- Publication number
- CN1511553A CN1511553A CNA021591997A CN02159199A CN1511553A CN 1511553 A CN1511553 A CN 1511553A CN A021591997 A CNA021591997 A CN A021591997A CN 02159199 A CN02159199 A CN 02159199A CN 1511553 A CN1511553 A CN 1511553A
- Authority
- CN
- China
- Prior art keywords
- adds
- solution
- filter
- add
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000001754 anti-pyretic effect Effects 0.000 title claims abstract description 37
- 239000002221 antipyretic Substances 0.000 title claims abstract description 37
- 239000003814 drug Substances 0.000 claims abstract description 45
- 239000000463 material Substances 0.000 claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 21
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims abstract description 12
- 230000008569 process Effects 0.000 claims abstract description 5
- 241000951473 Schizonepeta Species 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 47
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 46
- 238000012360 testing method Methods 0.000 claims description 44
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 42
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 239000007788 liquid Substances 0.000 claims description 28
- 239000000706 filtrate Substances 0.000 claims description 20
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 16
- 238000002360 preparation method Methods 0.000 claims description 15
- 238000003756 stirring Methods 0.000 claims description 14
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 11
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 10
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 claims description 10
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 claims description 10
- 229960003321 baicalin Drugs 0.000 claims description 10
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000003208 petroleum Substances 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 9
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 8
- 239000000853 adhesive Substances 0.000 claims description 8
- 230000001070 adhesive effect Effects 0.000 claims description 8
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 8
- 239000012567 medical material Substances 0.000 claims description 8
- 238000001556 precipitation Methods 0.000 claims description 8
- 239000000741 silica gel Substances 0.000 claims description 8
- 229910002027 silica gel Inorganic materials 0.000 claims description 8
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 8
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 238000004809 thin layer chromatography Methods 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 7
- 239000013558 reference substance Substances 0.000 claims description 6
- 239000007921 spray Substances 0.000 claims description 6
- 238000012546 transfer Methods 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 5
- 240000004534 Scutellaria baicalensis Species 0.000 claims description 4
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 4
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000012043 crude product Substances 0.000 claims description 4
- 230000006837 decompression Effects 0.000 claims description 4
- 238000004821 distillation Methods 0.000 claims description 4
- 235000012736 patent blue V Nutrition 0.000 claims description 4
- 238000004321 preservation Methods 0.000 claims description 4
- 238000004064 recycling Methods 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 239000000341 volatile oil Substances 0.000 claims description 4
- 241000207929 Scutellaria Species 0.000 claims description 3
- 238000012850 discrimination method Methods 0.000 claims description 3
- 239000000829 suppository Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 2
- SZWVDIMOLCVGDZ-UHFFFAOYSA-N C(C)O.[N+](=O)([O-])C1=C(C=CC(=C1)[N+](=O)[O-])NN Chemical compound C(C)O.[N+](=O)([O-])C1=C(C=CC(=C1)[N+](=O)[O-])NN SZWVDIMOLCVGDZ-UHFFFAOYSA-N 0.000 claims description 2
- 239000000443 aerosol Substances 0.000 claims description 2
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 238000001514 detection method Methods 0.000 claims description 2
- 239000006196 drop Substances 0.000 claims description 2
- 239000000945 filler Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- -1 masticatory Substances 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000000047 product Substances 0.000 claims description 2
- 229920006395 saturated elastomer Polymers 0.000 claims description 2
- 239000000377 silicon dioxide Substances 0.000 claims description 2
- OVYTZAASVAZITK-UHFFFAOYSA-M sodium;ethanol;hydroxide Chemical compound [OH-].[Na+].CCO OVYTZAASVAZITK-UHFFFAOYSA-M 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 238000011003 system suitability test Methods 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 239000012085 test solution Substances 0.000 claims description 2
- 239000003860 topical agent Substances 0.000 claims description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 claims description 2
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 claims description 2
- 235000012141 vanillin Nutrition 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims 1
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 claims 1
- 238000003810 ethyl acetate extraction Methods 0.000 claims 1
- 238000004811 liquid chromatography Methods 0.000 claims 1
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 abstract 1
- 235000001405 Artemisia annua Nutrition 0.000 abstract 1
- 240000000011 Artemisia annua Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 241000050051 Chelone glabra Species 0.000 abstract 1
- 244000037364 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 229940041616 menthol Drugs 0.000 abstract 1
- 230000036760 body temperature Effects 0.000 description 18
- 241000700159 Rattus Species 0.000 description 15
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 14
- 241000283973 Oryctolagus cuniculus Species 0.000 description 12
- 206010037660 Pyrexia Diseases 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 7
- 241000699670 Mus sp. Species 0.000 description 6
- 239000002510 pyrogen Substances 0.000 description 6
- 235000020183 skimmed milk Nutrition 0.000 description 6
- UFBJCMHMOXMLKC-UHFFFAOYSA-N 2,4-dinitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1[N+]([O-])=O UFBJCMHMOXMLKC-UHFFFAOYSA-N 0.000 description 5
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 5
- 208000037386 Typhoid Diseases 0.000 description 5
- 230000003110 anti-inflammatory effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 229960005489 paracetamol Drugs 0.000 description 5
- 230000002685 pulmonary effect Effects 0.000 description 5
- 201000008297 typhoid fever Diseases 0.000 description 5
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 4
- 229960001138 acetylsalicylic acid Drugs 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010057190 Respiratory tract infections Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- 229940031937 polysaccharide vaccine Drugs 0.000 description 3
- 238000005057 refrigeration Methods 0.000 description 3
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 3
- 241000712461 unidentified influenza virus Species 0.000 description 3
- 241001500351 Influenzavirus A Species 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 206010033971 Paratyphoid fever Diseases 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 230000003616 anti-epidemic effect Effects 0.000 description 2
- 210000000436 anus Anatomy 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 210000005069 ears Anatomy 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- IQUPABOKLQSFBK-UHFFFAOYSA-M 2-nitrophenolate Chemical compound [O-]C1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-M 0.000 description 1
- 240000006409 Acacia auriculiformis Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- JWHHANVGNNWIRI-UHFFFAOYSA-N methanol phosphoric acid hydrate Chemical compound O.OC.OP(O)(O)=O JWHHANVGNNWIRI-UHFFFAOYSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02159199 CN1244336C (zh) | 2002-12-30 | 2002-12-30 | 一种小儿退热药物及其制备方法和质量控制方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 02159199 CN1244336C (zh) | 2002-12-30 | 2002-12-30 | 一种小儿退热药物及其制备方法和质量控制方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1511553A true CN1511553A (zh) | 2004-07-14 |
CN1244336C CN1244336C (zh) | 2006-03-08 |
Family
ID=34237359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 02159199 Expired - Fee Related CN1244336C (zh) | 2002-12-30 | 2002-12-30 | 一种小儿退热药物及其制备方法和质量控制方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1244336C (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102327349A (zh) * | 2011-09-23 | 2012-01-25 | 蔡敏泽 | 一种婴幼儿速效退热散 |
CN102552404A (zh) * | 2011-12-30 | 2012-07-11 | 苏州爱斯欧蒂生物科技有限公司 | 一种退热药 |
CN102793876A (zh) * | 2012-09-05 | 2012-11-28 | 成都中医药大学 | 一种治疗不明原因发热的药物组合物及其制备方法和用途 |
CN103954724A (zh) * | 2014-04-28 | 2014-07-30 | 四川逢春制药有限公司 | 荆防颗粒的检测方法 |
CN104189609A (zh) * | 2014-09-19 | 2014-12-10 | 商丘爱己爱牧动物药业有限公司 | 一种兽用解热中药复方制剂 |
CN109030699A (zh) * | 2018-06-26 | 2018-12-18 | 哈尔滨市康隆药业有限责任公司 | 一种无糖型感冒止咳颗粒质量检测方法 |
-
2002
- 2002-12-30 CN CN 02159199 patent/CN1244336C/zh not_active Expired - Fee Related
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102327349A (zh) * | 2011-09-23 | 2012-01-25 | 蔡敏泽 | 一种婴幼儿速效退热散 |
CN102552404A (zh) * | 2011-12-30 | 2012-07-11 | 苏州爱斯欧蒂生物科技有限公司 | 一种退热药 |
CN102793876A (zh) * | 2012-09-05 | 2012-11-28 | 成都中医药大学 | 一种治疗不明原因发热的药物组合物及其制备方法和用途 |
CN103954724A (zh) * | 2014-04-28 | 2014-07-30 | 四川逢春制药有限公司 | 荆防颗粒的检测方法 |
CN104189609A (zh) * | 2014-09-19 | 2014-12-10 | 商丘爱己爱牧动物药业有限公司 | 一种兽用解热中药复方制剂 |
CN104189609B (zh) * | 2014-09-19 | 2017-05-17 | 商丘爱己爱牧生物科技股份有限公司 | 一种兽用解热中药复方制剂 |
CN109030699A (zh) * | 2018-06-26 | 2018-12-18 | 哈尔滨市康隆药业有限责任公司 | 一种无糖型感冒止咳颗粒质量检测方法 |
CN109030699B (zh) * | 2018-06-26 | 2020-09-18 | 哈尔滨市康隆药业有限责任公司 | 一种无糖型感冒止咳颗粒质量检测方法 |
Also Published As
Publication number | Publication date |
---|---|
CN1244336C (zh) | 2006-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1876139A (zh) | 治疗小儿厌食症的药物制剂及其制备方法和质量控制方法 | |
CN1931205A (zh) | 罗布麻属植物罗布麻叶总黄酮提取物、其制备及应用 | |
CN101040915A (zh) | 一种双黄连注射液的制备方法及其成分检测方法 | |
CN1768854A (zh) | 一种具有补脾益肠作用的中药胶囊制剂 | |
CN1876161A (zh) | 治疗乳腺增生的乳癖康药物制剂及制法和质量控制方法 | |
CN1244336C (zh) | 一种小儿退热药物及其制备方法和质量控制方法 | |
CN1305512C (zh) | 治疗乳腺增生的中药复方及其制备方法 | |
CN1843458A (zh) | 治疗慢性咽喉炎的泡腾片及制备方法和质量控制方法 | |
CN1813860A (zh) | 一种脑心清分散片及其制备工艺 | |
CN1872199A (zh) | 一种中药组合物及其制备方法 | |
CN1186051C (zh) | 一种化痰止咳的药物及其生产方法 | |
CN1304038C (zh) | 一种治疗阴道炎的药物组合物及其制备和质量控制方法 | |
CN1857385A (zh) | 一种治疗颈椎病的药物组合物及其制备方法 | |
CN1712034A (zh) | 一种中药组合物及其制备方法和质量控制方法 | |
CN1839863A (zh) | 一种治疗糖尿病的药物组合物及其制备方法和用途 | |
CN1194743C (zh) | 一种治疗类风湿性关节炎的中药组合物及其制备方法和质量控制方法 | |
CN100344312C (zh) | 一种治疗儿童多动症的颗粒剂的制备方法和质量控制方法 | |
CN1605357A (zh) | 胡芦巴提取物及其制备方法和应用 | |
CN1861106A (zh) | 复方板蓝根泡腾片及其制备方法 | |
CN1565611A (zh) | 一种治疗肩周炎的中药组合物及其制备方法 | |
CN1279931C (zh) | 一种治疗原发性、继发性头痛的药物 | |
CN1264531C (zh) | 一种治疗慢性原发性肾小球肾炎的中药组合物及其制备方法和质量控制方法 | |
CN1754554A (zh) | 一种中药组合物 | |
CN1559527A (zh) | 一种复方百部止咳药物及其制备方法 | |
CN1552414A (zh) | 一种中药组合物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Beijing Herun Chuangxin Pharmaceutical Technology Development Co., Ltd. Assignor: Dai Long Contract fulfillment period: 2008.12.2 to 2022.12.1 contract change Contract record no.: 2009990000512 Denomination of invention: Infantile antipyretic Granted publication date: 20060308 License type: Exclusive license Record date: 2009.5.15 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.12.2 TO 2022.12.1; CHANGE OF CONTRACT Name of requester: BEIJING HERUN CHUANGXIN MEDICINE SCIENCE AND TECHN Effective date: 20090515 |
|
ASS | Succession or assignment of patent right |
Owner name: KAIRUI INNOVATION MEDICINE TECH CO., LTD., BEIJING Free format text: FORMER OWNER: DAI LONG Effective date: 20101231 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 250014 SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE, NO.53, JINGSHI ROAD, JI NAN CITY, SHANDONG PROVINCE TO: 100086 ROOM 1706B3, QINGYUN DANGDAI BUILDING, BUILDING 9, MANTING FANGYUAN RESIDENTIAL QUATER, QINGYUNLI, HAIDIAN DISTRICT, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20101231 Address after: 100086 Beijing city Haidian District Qingyun aromatic garden Ting Building 9, Tsing Wun contemporary building room 1706B3 Patentee after: Beijing Kairui Chuangxin Pharmaceutical Sci. & Tech. Co., Ltd. Address before: 250014 Shandong, Ji'nan Province, No. ten, No. 53, Shandong University of Traditional Chinese Medicine Patentee before: Dai Long |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060308 Termination date: 20131230 |